Randomized Phase III Trial of the need for adjuvant chemotherapy in stage I epithelial ovarian cancer after comprehensive staging surgery - Randomized Trial of the need for adjuvant chemotherapy in stage I epithelial ovarian cancer

Japanese Gynecologic Oncology Group0 个研究点目标入组 360 人开始时间: 2012年7月20日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1) FIGO Stages IC2, IC3 2) Patients containing sarcoma elements 3) Patients with any signs of interstitial pneumonia or pulmonary fibrosis by chest radiography and CT 4) Patients with serious complications 5) Patients with active infection 6) Patients with intestinal paralysis or intestinal obstruction 7) Patients who have a synchronous malignancy or who have been progression-free less than 5 years for a metachronous malignancy 8) Patients with previous chemotherapy or radiation therapy 9) Patients with serious drug hypersensitivity 10) Patients with peripheral motor/sensory neuropathy (grade2,3,4 CTC-AE 4.0) 11) Patients who have had a hypersensitivity reaction to polyoxyethylated or hydrogenated castor oil 12) Patients with positive HBsAg.Patients with more than 2.1 log/copies ml based on fixed HBV-DNA who are positive with either antigen-positive HBs, anti-hepatitis B core antigen or anti-hepatitis B surface antigen. 13) Patients who are inappropriate to enter this study with any safety reasons, judged by the treating physician

发起方